Signaling Pathway
Relfovetmab is a monoclonal antibody that targets nerve growth factor (NGF). This antibody is specifically designed to bind and inhibit NGF, a key molecule involved in the regulation of pain and inflammation. Relfovetmab's mechanism of action makes it a valuable tool for research into pain management and the biological pathways of inflammation.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Relfovetmab is a monoclonal antibody that targets nerve growth factor (NGF). This antibody is specifically designed to bind and inhibit NGF, a key molecule involved in the regulation of pain and inflammation. Relfovetmab's mechanism of action makes it a valuable tool for research into pain management and the biological pathways of inflammation. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
